PALO ALTO, Calif. & MINNEAPOLIS, Minn.–(BUSINESS WIRE)–GERO, a leading AI-driven biotechnology company focused on aging…
High-performance storage accelerator provides 200Gbps throughput and is scalable to 3.2Tbps CARLSBAD, Calif.–(BUSINESS WIRE)–#connectivity–MaxLinear, Inc….
Cash of approximately $18.0 million as of June 30, 2023, provides ample runway to fund…
Cash of approximately $18.0 million as of June 30, 2023, provides ample runway to fund…
Data presented at The Autoimmunity Conference hosted by the Federation of American Societies for Experimental…
Data presented at The Autoimmunity Conference hosted by the Federation of American Societies for Experimental…
Offering includes participation from both new and existing healthcare-dedicated investors Proceeds extend the company’s cash…
Offering includes participation from both new and existing healthcare-dedicated investors Proceeds extend the company’s cash…
LAWRENCEVILLE, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development…
LAWRENCEVILLE, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development…
FREMONT, CA, Aug. 07, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC)…
FREMONT, CA, Aug. 07, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC)…
BASKING RIDGE, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”…
BASKING RIDGE, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”…
JUPITER, Fla., Aug. 07, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”,…
JUPITER, Fla., Aug. 07, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”,…
MARLBOROUGH, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences , Inc. (Nasqad: AKYA)(“Akoya), The…
MARLBOROUGH, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences , Inc. (Nasqad: AKYA)(“Akoya), The…
PRINCETON, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage…
PRINCETON, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage…